DGAP-News
Carl Zeiss Meditec AG: At the ESCRS 2014 ZEISS is offering cataract surgeons a greater diversity of products for enhanced safety and presenting a new product line for basic diagnostics - Seite 2
treatment of cataract patients. The introduction of the monofocal IOL CT
LUCIA is sharply focused on doctors who prefer the hydrophobic C-loop
design. Thanks to the innovative preloaded injector system, the surgeons
benefit from straightforward and efficient workflows, and patients from
optimal refractive outcomes1 through special ZEISS optics. ZEISS now offers
the most comprehensive IOL portfolio on the market. The new lens rounds off
the well-established range of hydrophilic MICS IOLs with an extensive
diopter range.
Furthermore, ZEISS can now provide its customers with a more comprehensive
offering for basic ophthalmic diagnostics than ever before: The Essential
Line provides all eye specialists with access to ZEISS quality from the
start and includes not only the proven slit lamps with imaging functions,
but also products for objective and subjective refraction, examinations of
the retina and measurement of intraocular pressure. The new offering
includes the VISUPHOR(R) 500 digital phoropter, the VISUSCREEN(R) 100/ 500
acuity charts and the portable VISUSCOUT(R) 100 fundus camera.
Anzeige
At ESCRS/EURETINA, ZEISS will also be showing major additions to its
offerings of retina and glaucoma diagnostic products. The new FORUM Retina
Workplace presents data in an intuitive Triple Display: OCT data are
automatically registered to fundus images and thickness and volume values
are shown over time. At a glance, doctors can compare current and prior
images as well as measurements to help them quickly determine the best
treatment plan.
In the area of glaucoma, ZEISS will be previewing its wide view tools for
glaucoma assessment: the new Anterior Segment Package and PanoMap for
CIRRUS HD-OCT. ZEISS is the first company to present a full anterior
chamber image in its retinal OCT products to help doctors identify patients
at risk for angle closure. The Anterior Segment Package also introduces OCT
Goniometry, a non-contact method of quantifying and tracking angle status.
High-definition angle scans reveal anatomical details facilitating
placement of the measurement tools. The new CIRRUS PanoMap combines macular
and disc maps in a single wide field display to make visible structural
damage across the entire posterior pole. The new retina and glaucoma
offerings will be available early next year.
"We see ourselves as a solutions provider in ophthalmology and aim to
optimally support our customers along the entire diagnostic and treatment
chain," says Dr. Ludwin Monz, CEO of Carl Zeiss Meditec AG. "Our goal is to
enable eye specialists to achieve the best possible clinical result for
offerings of retina and glaucoma diagnostic products. The new FORUM Retina
Workplace presents data in an intuitive Triple Display: OCT data are
automatically registered to fundus images and thickness and volume values
are shown over time. At a glance, doctors can compare current and prior
images as well as measurements to help them quickly determine the best
treatment plan.
In the area of glaucoma, ZEISS will be previewing its wide view tools for
glaucoma assessment: the new Anterior Segment Package and PanoMap for
CIRRUS HD-OCT. ZEISS is the first company to present a full anterior
chamber image in its retinal OCT products to help doctors identify patients
at risk for angle closure. The Anterior Segment Package also introduces OCT
Goniometry, a non-contact method of quantifying and tracking angle status.
High-definition angle scans reveal anatomical details facilitating
placement of the measurement tools. The new CIRRUS PanoMap combines macular
and disc maps in a single wide field display to make visible structural
damage across the entire posterior pole. The new retina and glaucoma
offerings will be available early next year.
"We see ourselves as a solutions provider in ophthalmology and aim to
optimally support our customers along the entire diagnostic and treatment
chain," says Dr. Ludwin Monz, CEO of Carl Zeiss Meditec AG. "Our goal is to
enable eye specialists to achieve the best possible clinical result for
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte